Therapeutic downregulation of core circuitry genes in mutant MYOD1 rhabdomyosarcoma
Therapeutic downregulation of core circuitry genes in mutant MYOD1 rhabdomyosarcoma
Dr. Berkley Gryder, Ph.D. – Case Western Reserve University School of Medicine, Cleveland, OH
Cooperative mutagenesis driving pediatric pre-B cell leukemia
Cooperative mutagenesis driving pediatric pre-B cell leukemia
Dr. Abby Green, M.D. – Washington University, School of Medicine, St. Louis, MO
Preclinical evaluation of omacetaxine as a novel therapeutic for ATRT
Preclinical evaluation of omacetaxine as a novel therapeutic for ATRT
Dr. John Prensner, M.D., Ph.D. – University of Michigan Medical Center (Michigan Medicine), Ann Arbor, MI
Validating PRL2 as a New Therapeutic Target in T-ALL
Validating PRL2 as a New Therapeutic Target in T-ALL
Dr. Loretta Li, M.D. – Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL
Brain Network Organization and Long-Term Cognitive Outcome in Pediatric Brain Tumor Patients
Brain Network Organization and Long-Term Cognitive Outcome in Pediatric Brain Tumor Patients
Dr. Stephanie Perkins – Washington University in St. Louis, St Louis, MO
Delineating molecular mechanisms of metastatic dissemination for medulloblastoma therapy
Delineating molecular mechanisms of metastatic dissemination for medulloblastoma therapy
Dr. Baoli Hu – University of Pittsburgh, Pittsburgh, PA
Characterizing the ENL YEATS epigenetic reading domain as a therapeutic target in pediatric MLL-ENL leukemias
Characterizing the ENL YEATS epigenetic reading domain as a therapeutic target in pediatric MLL-ENL leukemias
The Regents of the University of Michigan, Ann Arbor, MI
Investigating the role of PSAT1 in tumor-associated macrophages for sarcoma immunotherapy
Investigating the role of PSAT1 in tumor-associated macrophages for sarcoma immunotherapy
Case Western Reserve University - School of Medicine, Cleveland, OH
First-in-class oral inhibitor of TGF-beta receptor in humanized mouse model of advanced osteosarcoma
First-in-class oral inhibitor of TGF-beta receptor in humanized mouse model of advanced osteosarcoma
Case Western Reserve University School of Medicine, Cleveland, OH
Polycomb inhibition sensitizes AML to anthracycline therapy
Polycomb inhibition sensitizes AML to anthracycline therapy
The Research Institute at Nationwide Children’s Hospital, Columbus, OH
Pediatric Cancer Data Commons
Pediatric Cancer Data Commons
University of Chicago, Chicago, Illinois
L3MBTL3, A Therapeutic Target in Acute Myeloid Leukemia
L3MBTL3, A Therapeutic Target in Acute Myeloid Leukemia
The Regents of the University of Michigan, Ann Arbor, MI
Targeting MEK and CDK4/6 in DIPG
Targeting MEK and CDK4/6 in DIPG
Lurie Children’s Hospital, Chicago, IL
‘Eyes Absent’ Gene Investigation in Ewing’s Sarcoma Patients
‘Eyes Absent’ Gene Investigation in Ewing’s Sarcoma Patients
Cincinnati Children’s Hospital, Cincinnati, OH
Reversing NK Cell Dysfunction in Pediatric Cancer
Reversing NK Cell Dysfunction in Pediatric Cancer
Case Western Reserve University, Cleveland, OH